{"editorial":{"content_id":"4110f8c5-8ea7-4620-b7d0-46fb6f989d77","slug":"futuro-explica-20261012-33b662","content_type":"news","title":"巴西健康媒体Futuro Explica新一期聚焦生物类似药市场与监管","summary":"巴西健康媒体Futuro da Saúde旗下栏目Futuro Explica推出新一期节目，探讨生物类似药市场及其监管进展。","body":"巴西健康领域媒体Futuro da Saúde旗下栏目Futuro Explica推出新一期节目，主题为生物类似药（biossimilares）市场及其监管方面的进展，并探讨生物类似药如何影响健康。\n\n原文仅披露了该期节目的主题与发布信息，未提供具体嘉宾、数据或结论。","why_it_matters":null,"cbi_observation":null,"direction_tag":"巴西","primary_category":"科技平台","secondary_topics":["行业趋势","合规","br-health"],"content_level":"编辑整理","event_type":"行业趋势","audience_tags":[],"event_location":null,"verification_status":"unverified","published_at":"2026-10-12T17:01:02.220Z","display_date":"2026-10-12","source_published_at":null,"source_url":"https://futurodasaude.com.br/biossimilares-saude-futuro-explica/","source_name":"Futuro da Saúde","source_language":"pt","author_name":"编辑部","risk_level":"medium","risk_flags":[],"opportunity_flags":[],"trend_signals":[]},"intelligence":null,"meta":{"canonical_url":"https://chinabrazilinsight.com/news/futuro-explica-20261012-33b662","api_url":"https://chinabrazilinsight.com/api/public/content/futuro-explica-20261012-33b662","markdown_url":"https://chinabrazilinsight.com/api/public/content/futuro-explica-20261012-33b662?view=markdown","json_url":"https://chinabrazilinsight.com/api/public/content/futuro-explica-20261012-33b662?view=json","last_updated":"2026-10-12T17:01:29.200Z","platform":"China Brazil Insight","platform_url":"https://chinabrazilinsight.com"}}